A A A

News & Medical Papers

 

For current guidelines and updates from within the arrhythmia healthcare community please visit Arrhythmia Watch.

Post-cardiac Device Implantation Movement and Mobilisation Advice Survey

Peterborough and Stamford Hospitals NHS Foundation Trust, 26 April 2016

This survey is being carried out by the Cardiology Research Team at the Peterborough and Stamford Hospitals NHS Foundation Trust in Cambridgeshire.

Take part in the survey here


 

Rate vs Rhythm for Post-op AF: Neutral Trial, Positive Message

Medscape, 19 April 2016

John M. Mandrola, MD, interviews A. Marc Gillinov, MD, who presented the Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery trial[1] at the 2016 American College of Cardiology (ACC) scientific sessions on behalf of the Cardiothoracic Surgical Trials Network (CTSN).

Watch here


Opportunistic screening of atrial fibrillation by automatic blood pressure measurement in the community

BMJ Open, 13 April 2016

Timely detection of atrial fibrillation (AF) may effectively prevent cardiovascular consequences. However, traditional diagnostic tools are either poorly reliable (pulse palpation) or not readily accessible (ECG) in general practice. We tested whether an automatic oscillometric blood pressure (BP) monitor embedded with an algorithm for AF detection might be effective for opportunistic screening of asymptomatic AF in the community.

Read more


 

Tens of millions to be reinvested in patient care thanks to NHS devices deal

NHS England, 13 April 2016

NHS England has today announced a new nationwide system for purchasing expensive medical devices and implants which will see savings of over £60 million ploughed back into specialist care in its first two years.

Read more


Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor

PR Newswire, 12 April 2016

BioMonitor 2 is designed to provide physicians with the ability to accurately detect and diagnose atrial fibrillation, ventricular tachycardia and fibrillation, and syncope. The device can also be used to monitor atrial events in patients who have undergone ablation procedures.

Read more


Mobile Technology May Screen for Afib

MedPage Today, 9 April 2016

Hand-held devices such as smartphones can be adapted to allow the phone to monitor a person's heart and detect atrial fibrillation with a high degree of accuracy, researchers reported here.

Read more


Unexpected Loss of Life Partner Raises Risk of Atrial Fibrillation in Bereaved Spouse

Medical Research, 7 April 2016

Our study reports that spousal bereavement is followed by a transiently increased risk of new onset of atrial fibrillation (AF). The risk was highest 8-14 days after the loss and remains elevated for one year.

Read more


Remote Monitoring Reduces Expenditures Associated with Implantable Cardioverter Defibrillators

Medical Research, 6 April 2016

While cardiac implantable electronic devices (CIEDs) are increasingly used to treat patients with arrhythmias, heart failure, and other risk factors for sudden cardiac death, these implantable devices require life-long follow-up to assess their performance and functionality.

Read more


FDA approves first leadless pacemaker to treat heart rhythm disorders

FDA, 6 April 2016

The U.S. Food and Drug Administration today approved the first pacemaker that does not require the use of wired leads to provide an electrical connection between the pulse-generating device and the heart. While the Micra Transcatheter Pacing System works like other pacemakers to regulate heart rate, the self-contained, inch-long device is implanted directly in the right ventricle chamber of the heart.

Read more


 

Patient's personal activity tracker, smartphone can help physicians treat new-onset atrial fibrillation

News Medical, 6 April 2016

Emergency physicians used a patient's personal activity tracker and smartphone to identify the time his heart arrhythmia started, which allowed them to treat his new-onset atrial fibrillation with electrical cardioversion and discharge him home. The first case report using information in an activity tracker/smartphone system to assist in medical decision-making was reported online Friday in Annals of Emergency Medicine ("Interrogation of Patient Activity Tracker to Assist Arrhythmia Management").

Read more


Irregular heart rhythm may affect walking and strength in older adults

EurekAlert, 5 April 2016

When older people develop atrial fibrillation -- the most common type of irregular heartbeat -- it accelerates age-related declines in walking speed, strength, balance and other aspects of physical performance, according to new research in Circulation: Arrhythmia and Electrophysiology, an American Heart Association journal.

Read more


Mixed results on benefits of antiarrhythmic drugs for out-of-hospital cardiac arrest

Medical Press, 4 April 2016

Paramedics often give heart rhythm stabilizing drugs to patients who are suffering out-of-hospital cardiac arrest when they fail to regain a stable heart rhythm after electrical shock treatment. In a study presented at the American College of Cardiology's 65th Annual Scientific Session, these drugs, specifically amiodarone and lidocaine, did not significantly improve such patients' likelihood of surviving to hospital discharge overall. However, among patients whose cardiac arrest was witnessed by a bystander, those who received either amiodarone or lidocaine during resuscitation had a 5 percent greater chance of survival to hospital discharge compared with those who received a placebo, which was a statistically significant difference. Witnessed cardiac arrests represented more than half of the study's population.

Read more


EnduraLife™ Battery Technology The journey to Meaningful Difference

Boston Scientific, 30 March 2016

Discover why longer battery life gives CRT-D patients more

Read more


CE mark approval granted for new St Jude Medical Quartet quadripolar pacing leads

Cardiac Rhythm News, 30 March 2016

St Jude Medical has announced the launch and CE mark approval for three new Quartet left ventricular (LV) leads.

Read more


Presence of a wide and large S-wave in lead I is a powerful predictor of life-threatening ventricular arrhythmias in Brugada Syndrome patients

Cardiac Rhythm News, 30 March 2016

New research published in the Journal of the American College of Cardiology indicates that a wide/and or large S-wave in lead I is a powerful predictor of life-threatening ventricular arrhythmias in Brugada Syndrome patients with no history of cardiac arrest at presentation.

Read more


 

AHA releases advisory proposing wearable defibrillators as potential treatment option

Cardiac Rhythm News, 29 March 2016

A wearable automatic defibrillator may be an option for patients who are at risk for life-threatening heart rhythm abnormalities but are not good candidates for an implantable cardiac defibrillator (ICD), according to an advisory from the American Heart Association, published in its Circulation journal.

Read more


Wearable defibrillator may be an alternative to ICD for some patients

Medical Press, 28 March 2016

A wearable automatic defibrillator may be an option for patients who are at risk for life-threatening heart rhythm abnormalities but are not good candidates for an implantable cardiac defibrillator (ICD), according to an advisory from the American Heart Association, published in its Circulation journal.

Read more


 

 

Real-World Data on XARELTO® in Patients with Non-Valvular Atrial Fibrillation and Diabetes Among 14 Presentations at American College of Cardiology's 65th Annual Scientific Session

PR Newswire, 21 March 2016

Janssen Pharmaceuticals, Inc., and its development partner, Bayer, today announced that 14 data presentations will be presented at the American College of Cardiology's 65th Annual Scientific Session (ACC.16), including real-world findings confirming the safety of XARELTO® (rivaroxaban) in a high-risk group of patients with non-valvular atrial fibrillation (NVAF) and concomitant diabetes. This real-world research complements the XARELTO® clinical trials by providing important insights to physicians on how the medicine is performing in patients seen in everyday practice.

Read more


EKG on a Wristband: Review

MedPage Today, 21 March 2016

AliveCor this week introduced the Kardia Band for the Apple Watch, which will let users capture a single-lead EKG by just touching the watch's band.

Read more


 

FDA grants 510(k) clearance for InfoBionic MoMe Kardia

Cardiac Rhythm News, 18 March 2016

InfoBionic has received 510(k) clearance from the US Food and Drug Administration (FDA) for MoMe Kardia, a wireless, remote monitoring system designed to aid the diagnosis of cardiac arrhythmias in patients with a demonstrated need for cardiac monitoring.

Read more


 

Arrhythmogenic cardiomyopathy

BioMed Central, 16 March 2016

Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease clinically characterized by life-threatening ventricular arrhythmias and pathologically by an acquired and progressive dystrophy of the ventricular myocardium with fibro-fatty replacement. Due to an estimated prevalence of 1:2000-1:5000, AC is listed among rare diseases.

Read more


Atrial fibrillation patients at highest stroke risk not prescribed necessary medication

Medical Press, 16 March 2016

Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.

Read more


Hypertrophic cardiomyopathy patients at risk of sudden cardiac death may be eligible for S-ICD

Cardiac Rhythm News, 2 March 2016

Patients with hypertrophic cardiomyopathy at risk of sudden cardiac death and without pacing indication may be eligible for Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) implantation, according to results of a single-centre study.

Read more


Point-of-Care Warfarin Monitoring in the ROCKET AF Trial

The New England Journal of Medicine, 25 February 2016

In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF), investigators found that rivaroxaban was noninferior to warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Read more


Medtronic receives CE mark for three MRI-compatible cardiac resynchronisation therapy defibrillators

Cardiac Rhythm News, 22 February 2016

Medtronic has received CE mark for cardiac resynchronisation defibrillators (CRT-Ds) which are approved for 3 Tesla (T) magnetic resonance imaging (MRI) scans. These devices are the first and only CRT-Ds approved for this level of MRI, according to a company release.

Read more


FDA Panel provides recommendations on adverse events, long-term safety and postmarket surveillance of leadless pacemakers

Cardiac Rhythm News, 19 February 2016

The Food and Drug Administration (FDA)’s Circulatory System Devices Panel of the Medical Devices Advisory has made recommendations for leadless pacemakers regarding adverse events, long-term safety issues (including battery longevity), necessary elements for postmarket surveillance, indications for use and labelling, and implanting physicians’ training.

Read more


 St Jude Medical receives FDA approval for MultiPoint pacing technology

Cardiac Rhythm News, 18 February 2016

St Jude Medical has received US Food and Drug Administration approval for its MultiPoint pacing technology. This technology is designed to provide additional options which may benefit cardiac resynchronisation therapy patients who are not responsive to other methods of pacing.

Read more


AliveCor Heart Monitor used to detect postoperative atrial fibrillation after heart surgery

iMedicalApps, 18 February 2016

In a recent study, prescription of the AliveCor Heart Monitor to patients with an episode of atrial fibrillation (AF) after heart surgery improved detection of postoperative atrial fibrillation after discharge – even when no symptoms were present.

Read more


Robotically-guided approach offers alternative LV lead implantation through the coronary sinus

Cardiac Rhythm News, 18 February 2016

Left ventricular (LV) lead implantation for cardiac resynchronisation therapy (CRT) with a robotically-guided surgical approach through the coronary sinus seems to offer a new alternative when conventional approaches are not suitable, a new study has found.

Read more


What Every Pediatrician Should Know in 2016

Medscape, 16 February 2016

2015 was an exciting year with many interesting studies and innovations. This is also true for paediatrics. Here is my take on the top 5 topics that will change practice in 2016.

Read more


Short Battery Life of Cardiac Devices: A Scandal?

MedPage Today, 10 February 2016

The short battery life of cardiac devices, such as pacemakers and implantable cardioverter defibrillators (ICDs), is a "scandal," two cardiologists argued.

Read more


EMA concludes defective device in ROCKET study does not impact Xarelto’s safety

European Medicines Agency, 5 February 2016

The European Medicines Agency (EMA) has concluded that a defect with the international normalised ratio (INR) device used in the ROCKET study does not change its conclusions on the overall safety or benefit-risk balance of Xarelto (rivaroxaban). The ROCKET study was the main clinical trial underpinning the use of this anti-clotting medicine in patients with non-valvular atrial fibrillation (irregular heartbeat).

Read more


 

 

Implantation of multiple leadless pacemakers is feasible without impacting cardiac function

Cardiac Rhythm News, 5 February 2016

An animal study from China has indicated that it is feasible to implant two leadless pacemakers in the right ventricle of the same heart without impacting cardiac function at six months.

Read more


Cardiologists expose concerns regarding battery life of cardiac implantable electronic devices

Cardiac Rhythm News, 4 February 2016

The battery life of cardiac implantable electronic devices must be improved to reduce the need for replacement and the risks this carries for patients, argue UK cardiologists John Dean and Neil Sulke in an editorial published in BMJ.

Read more


Vasovagal Syncope and Driving

American College of Cardiology, 4 February 2016

What is the likelihood of a motor vehicle accident causing serious risk or harm in patients with frequent vasovagal syncope?

Read more


NICE targets stroke with possible new indicators for GPs and clinical commissioners

NICE, 1 February 2016

NICE – the National Institute for Health and Care Excellence – is consulting on potential new indicators for the NICE indicator menu. Indicators encourage health professionals to assess patients on a range of key health issues where diagnosis and treatment is supported by evidence-based guidelines. The aim is to tackle widespread public health challenges one patient at a time.

Read more


Stroke prevention in atrial fibrillation: we can do better

British Journal of General Practice, 1 February 2016

Atrial fibrillation (AF), an irregular and often rapid cardiac rhythm, is the most common sustained cardiac dysrhythmia.

Read more


 

MRI safe for patients with implantable cardiac devices

News Medical, 30 January 2016

The findings of a major study led by cardiovascular imaging specialists at Allegheny General Hospital (AGH), part of the Allegheny Health Network (AHN), suggest that magnetic resonance imaging is a safe and effective diagnostic procedure for patients with implantable cardiac devices. The research, believed to be the first ever focused solely on the value of MRI in this patient population, is being presented today at the annual Society of Cardiovascular MRI Scientific Sessions meeting in Los Angeles.

Read more


 

Driving and Vasovagal Syncope? Serious Accidents, Harm Rare

Medscape, 28 January 2016

Researchers estimate that the incidence of driving and having a serious accident causing bodily injury or death is much lower in patients with frequent vasovagal syncope than in the general population (<0.0035% per person year vs 0.067% per driver-year)[1]. The study was published online January 20, 2016 in JACC: Clinical Electrophysiology.

Read more


No need to get up! Doctors can accurately measure subtle changes in your heartbeat from across the room without touching you

Mail Online, 20 January 2016

Scientists are working on a method of detecting your heartbeat without sensors on the body, which they claim is as accurate as an electrocardiogram (ECG).

Read more


AliveCor Partners with LifeWatch to Expand Into Remote Patient Monitoring

AliveCor, 12 January 2016

AliveCor, Inc., the leader in FDA-cleared ECG technology for mobile devices, announced today a strategic partnership with LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer of medical solutions and remote diagnostic monitoring services to the digital health market. The AliveCor Mobile ECG will now be integrated into LifeWatch’s remote cardiac monitoring service, AliveCor’s first step into remote patient monitoring.

Read more


Has leadless pacing changed practice?

Cardiac Rhythm News, 18 January 2016

Since the implantation of the first pacemaker in humans in 1958, pacing for bradycardia has not changed substantially. While the art is mature, pacing still involves a surgical procedure to create a pocket for the pacemaker, and venous access to introduce one or more pacing leads into the cardiac chamber(s).

Read more


Women and men with heart failure benefit similarly from implantable cardioverter defibrillators

Cardiac Rhythm News, 18 January 2016

An analysis from the US Get with the guidelines for heart failure (GWTG-HF) registry has found that women and men with heart failure and reduced left ventricular ejection fraction benefit similarly from implantable cardioverter defibrillators (ICDs).

Read more


World's smallest pacemaker on trial in Princess Alexandra Hospital

Brisbane Times, 15 January 2016

A Queensland hospital is leading the Australian-first trial of the world's smallest pacemaker, labelled the biggest game changer in six decades.

Read more


Implantable Defibrillators Effective for Women Too

Medpage Today, 12 January 2016

Implantable cardioverter defibrillators (ICDs) boost survival for women and men with heart failure alike -- even if the benefits of ICDs haven't been as well studied for women -- according to a registry study.

Read more


 Zoll LiveVest wearable defibrillator receives FDA approval for paediatric use

Cardiac Rhythm News, 18 December 2015

Zoll Medical’s LiveVest wearable cardioverter defibrillator has been approved for a new paediatric indication by the US Food and Drug Administration. It is now approved for use by certain children who are at risk for sudden cardiac arrest, but who are not candidates for an implantable defibrillator device due to certain medical conditions, or a lack of parental consent.

Read more


First patient enrolled in international CEASE atrial fibrillation study

Cardiac Rhythm News, 17 December 2015

The first patient has been enrolled in the CEASE (combined endoscopic epicardial and percutaneous) atrial fibrillation (AF) clinical study, according to a press release from AtriCure.

Read more


 

Advances in left atrial appendage occlusion and peri-procedural challenges

Cardiac Rhythm News, 17 December 2015

Dhiraj Gupta (Liverpool, UK) overviews developments in two left atrial appendage (LAA) occlusion devices, which have helped make the implant procedure safer, easier and quicker. He also highlights current challenges related to overall peri-procedural patient management.

Read more


Arrhythmia & Electrophysiology Review (AER)

Radcliffe Cardiology, 14 December 2015

Volume 4 Issue 3 Winter 2015

View the eJournal's here


 

US cardiovascular societies publish joint expert consensus on left atrial appendage occlusion requirements

Cardiac Rhythm News, 11 December 2015

The Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) have published a joint document providing recommendations—for institutions and interested physicians—for the establishment and maintenance of left atrial appendage occlusion programmes performing left atrial appendage closure.

Read more


CRT-D Longevity Comparison Post-2006

Boston Scientific, 10 December 2015

NEW: An 8th independent longevity study with 3,436 patients shows that 97.6% of modern Boston Scientific CRT-Ds survive at 6 years, compared to only 46.3% of modern Medtronic CRT-Ds, once again showing that Boston Scientific CRT-Ds have significantly better survival than Medtronic CRT-Ds at 6-years post-implant1.

View more here


GPs face drive to prescribe warfarin alternatives under new NICE plans

Pulse Today, 10 December 2015

GPs face a drive to prescribe warfarin alternatives, as NICE has decided to consider new QOF indicators for anticoagulation control.

Read more


SUDEP May Share Genes With Sudden Cardiac Death

MedPage Today, 8 December 2015

Similar genes that are involved in cardiac arrhythmias may play a role in sudden unexplained death in epilepsy (SUDEP), researchers reported here.

Read more


Leicester City CCG shortlisted in Health Business Awards for its usage of INRstar analytics

SCSL Health, 7 December 2015

Leicester City CCG has been shortlisted within the Healthcare IT category of this year’s Health Business Awards for its usage of INRstar analytics.

Read more


Medtronic recalls InSync III pacemakers due to battery issue
03 December 2015

Medtronic confirms it has informed physicians and regulatory authorities of an issue with the long-term battery performance of its InSync® III cardiac resynchronization therapy-pacemakers (CRT-Ps).

It is important to note that the InSync III CRT devices are an older set of devices no longer being distributed. The company has confirmed 0.03 percent of implanted InSync III devices have been affected.
Patients who have this device and who have concerns or who experience new or unexpected symptoms associated with their heart condition should seek guidance from their physicians.


Boehringer Ingelheim's Praxbind gets European approval for specific reversal of Pradaxa

Pharmabiz, 28 November 2015

The European Commission has approved Boehringer Ingelheim's Praxbind (idarucizumab), a treatment to rapidly and specifically reverse the anticoagulant effects of Pradaxa (dabigatran etexilate) in cases of emergency surgery /urgent procedures or in situations of life-threatening or uncontrolled bleeding. Idarucizumab is the first specific reversal agent for a non-vitamin K antagonist oral anticoagulant (NOAC) to be approved in the European Union.

Read more


Atrial Fibrillation Stroke: SCSLhealth release new, Commissioner Guide on how to improve population coverage of anticoagulation for commissioners

SCSL Health, 25 November 2015

SCSLhealth – provider of the UK’s market leading software for AC management (INRstar) has announced the release of a new document to help Clinical Commissioning Groups (CCGs), Commissioning Support Units (CSUs) and Local Health Boards (LHBs) to improve population coverage of anticoagulation by outlining a suite of recommendations, tools and resources to support implementation of NICE Clinical Guidelines on the management of Atrial Fibrillation.

Read the full press release here
Download you FREE copy of the AF stroke report here


S-ICD System 2-Year Results - Pooled Analysis of the IDE Study and EFFORTLESS Registry

Boston Scientific, 24 November 2015

Watch the conclusions of the largest and most comprehensive S-ICD data set, with the longest follow-up to date here


Asymptomatic Atrial Fibrillation
The Case for Screening to Prevent Stroke

American Medical Association, 10 November 2015

Could unknown asymptomatic atrial fibrillation be detected easily as a way to prevent stroke?

Read more


 

Are energy drinks safe enough for the heart?

Cardiac News, 5 November 2015

Despite the lack of randomised trials on energy drinks consumption, few case reports on atrial and ventricular arrhythmias as well as on myocardial ischaemia inducted by energy drinks have raised concerns on the safety of these beverages.

Read more


 

World Stroke Day: Key Risk Factors Atrial Fibrillation and Hypertension Need Detection and Treatment

Pharmiweb, 28 October 2015

On World Stroke Day (29 October) a campaign by Daiichi Sankyo highlights stroke risks associated with cardiovascular diseases

Read more


Blackouts and near drownings may signal sudden death risk

Cardiac Rhythm News, 26 October 2015

Blackouts and near drownings may point to long QT syndrome (LQTS), signalling an increased risk of sudden death, according to research presented at the SA Heart Congress (25-28 October, Sun City, South Africa) by Paul Brink, professor of internal medicine at the University of Stellenbosch in Tygerberg, South Africa.

Read more


Dabigatran Reversal Drug Holds Promise

Medpage Today, 17 October 2015

Preliminary research suggests idarucizumab can reverse anticoagulant's bleeding risk

Read more


FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

FDA, 16 October 2015

The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects. 

Read more

Read Boehringer Ingelheim Press Release


AF Atrial Fibrillation Symposium

NWC AHSN, 26 June 2015

The North West Coast Academic Health Science Network is celebrating a successful event which looked at innovative new ways to tackle and manage Atrial Fibrillation (AF) - which causes irregular heartbeats and is a major cause of strokes.

Read more


CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Boehringer Ingelheim, 28 September 2015

Today, the Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending European approval of idarucizumab (to be marketed as Praxbind®).

Read more


European Medicines Agency recommends dabigatran antidote after accelerated assessment

Cardiac Rhythm News, 25 September 2015

The European Medicines Agency (EMA) has recommended granting a marketing authorisation, following accelerated assessment, for idarucizumab (Praxbind, Boehringer Ingelheim) as a specific antidote to dabigatran etexilate (Pradaxa, Boehringer Ingelheim) when rapid reversal of its effect is required. Idarucizumab is to be used when a patient taking dabigatran needs to undergo an emergency surgery or when life-threatening or uncontrolled bleeding occurs.

Read more


NICE approves new oral anti-coagulant for atrial fibrillation

Nursing Times, 24 September 2015

The drug edoxaban has been given the official seal of approval for NHS use in preventing stroke and blood clots in patients with a common heart disorder.

Read more


The Beauty of Subcutaneous ICDs Is Not Merely Skin Deep

Cardiovascular Business, 23 September 2015

Three decades and 1 million-plus implantations after its introduction, the transvenous implantable cardioverter-defibrillator (T-ICD) is facing stiff competition from a smaller, thinner, more versatile and longer lasting addition to the family tree of implantable devices that shock the heart to prevent sudden cardiac death.

Read more


Cohorts, Meta-Analysis: No Link Between Coffee and Increased Risk for Atrial Fibrillation

Medspace, 23 September 2015

More research is weighing in with a resounding "no" on whether downing coffee may be detrimental to cardiovascular health in otherwise-healthy adults.

Read more


Matters of the heartbeat: Electric irregularity a danger for many

tdtnews, 23 September 2015

Dr. Javier E. Banchs, cardiologist Baylor Scott & White — Central Division, director of electrophysiology and pacing, spoke about the medical problem at the Belton Senior Expo on Tuesday.

Read more


SJM™ Quadra CRT System

St. Jude Medical, 22 September 2015

The SJM™ Quadra family of devices, with the Quartet™ LV lead, set the standard for quadripolar technology. With 10+ years of design experience, 100+ publications and 100,000+ implants, the SJM Quadra CRT system is pioneering outcomes with proven performance and unmatched data.
The SJM Quadra CRT system is part of the comprehensive heart failure portfolio from St. Jude Medical.

Read more


Battery depletion in CRT Defibrillators by vendor

Boston Scientific, 22 September 2015

Dr. Ernest Lau's recent independent study showed a clinically meaningful difference in CRT-D longevity by manufacturer at six years.*

Read more


Recent ESC Guidelines to Identify Hypertrophic Cardiomyopathy Patients at High Risk for Sudden Death Are Unreliable

Alpha Galileo, 21 September 2015

Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.

Read more


FIRST LOOK: Huntsville Hospital expands electrophysiology services

Tech Alabama, 18 September 2015

Huntsville Hospital is giving Tech Alabama a first look at its newest electrophysiology lab.

Read more


 Laguna Pharmaceuticals initiates phase 3 study of vanoxerine in atrial fibrillation and atrial flutter -

Cardiac Rhythm News, 17 September 2015

The study, known as RESTORE SR, will enrol 600 patients at trial sites in the USA and other countries and will evaluate vanoxerine at a 400mg dose. In the phase 2b COR-ART study, this dose was effective in restoring sinus rhythm in greater than 80% of patients, a level approaching that of the leading intervention—delivery of electrical shock to the heart with direct current cardioversion.

Read more


Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation

HospiMedica, 17 September 2015

A new study concludes that first-line treatment with radiofrequency ablation (RFA) is superior to antiarrhythmic drug therapy (AAD) for reducing atrial fibrillation (AF).

Read more


Medtronic Wins FDA Clearance For First MRI-Safe ICD

Med Device Online, 16 September 2015

Medtronic announced that it has gained U.S. Food and Drug Administration (FDA) approval for the first-ever implantable cardioverter defibrillator (ICD) device that can be safely used by patients undergoing full-body magnetic resonance imaging (MRI) scans.

Read more


Health Report: Alternatives to drugs offer new ways to treat Atrial Fibrillation

KUSI News, 16 September 2015

According to the National Institute of Health, most adults have an average heart rate of 60 to 100 beats per minute. Most of the time, you don’t think about how fast your heart is beating unless you’re exercising, feeling stressed -- or have cardiac arrhythmia.

Read more


Area doctors keep an eye on the heart's electrical system

Portland Tribune, 15 September 2015

Electrophysiology is one of the fasted growing fields in cardiac care, and at Northwest Regional Heart and Vascular (Adventist Medical Center in Portland), Dr. Fawaz Alhumaid and colleagues are hard at work analyzing the heart’s rhythm and electrical conduction system.

Read more


CardioFocus' HeartLight PMA for the treatment of atrial fibrillation filed and accepted for review by the FDA

Cardiac Rhythm News, 15 September 2015

CardioFocus’ Premarket Approval (PMA) application for its HeartLight device has been filed and accepted for review by the US Food and Drug Administration (FDA). The accepted PMA application includes safety and effectiveness data from the company’s multicentre HeartLight pivotal clinical trial, a randomised, controlled study in which a total of 353 patients were treated at 19 leading arrhythmia centres across the USA.

Read more


LEADLESS II shows positive safety and efficacy outcomes with Nanostim

Cardiac Rhythm News, 15 September 2015

Primary results from the LEADLESS II study have shown positive efficacy and safety outcomes with the Nanostim leadless pacemaker (St Jude Medical) for patients who require a single-chamber ventricular pacemaker.

Read more


An aspirin a day DOES help prevent heart attack, stroke and colon cancer - but it's most effective if you're in your 50s

Daily Mail, 14 September 2015

A daily low dose of aspirin should be given to people in their 50s to prevent a heart attack or stroke, new guidelines recommend.

Read more


3D imaging of kids' hearts

News4Jax, 14 September 2015

More than 4 million Americans are living with heart arrythmias meaning they have hearts that don't always beat in a steady rhythm.

Read more


Apixaban Cost-Effective in Afib Patients With Low Stroke Risk

Medpage Today, 14 September 2015

Treatment with apixaban (Eliquis) versus aspirin was associated with fewer strokes but more bleeding episodes in nonvalvular atrial fibrillation patients with a low risk for stroke in the first study to compare the cost-effectiveness of a non-VKA oral anticoagulant (NOAC) with aspirin in this population.

Read more


First MRI-conditional implantable cardioverter defibrillator system receives FDA approval

Cardiac Rhythm News, 14 September 2015

Medtronic has announced that it has received the first US Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator (ICD) system for use with magnetic resonance imaging (MRI) scans.

Read more


Stroke Rounds: Anticoagulation After Afib Ablation

Medpage Today, 10 September 2015

Atrial fibrillation ablation quells symptoms and has other benefits, but is stroke prevention one of them?

Read more


Procedure Does Not Reduce Stroke Risk in Patients with Atrial Fibrillation

HCP Live, 9 September 2015

Left atrial appendage obliteration reduces stroke risk in patients with nonvalvular atrial fibrillation (AF), but a new study suggests that the procedure does not reduce stroke risk in AF patients after bioprosthetic mitral valve replacement.

Read more


Electrical left atrial appendage isolation helps to improve freedom from long-standing persistent AF

Cardiac Rhythm News, 7 September 2015

A randomised, multicentre study has found improvement in the long-term freedom from long-standing persistent atrial fibrillation (AF) in patients who underwent an ablation plus empirical electrical left atrial appendage isolation strategy. No major complications were reported.

Read more


ESC: Declining Renal Function May Be Bad News in Afib

MedPage Today, 3 September 2015

Patients with atrial fibrillation who also had declining renal function based on estimated glomerular filtration rates (eGFR) were significantly more likely to experience cardiovascular events, researchers reported here.

Read more


Stroke Rounds: Seizures More Common in Afib

MedPage Today, 3 September 2015

New-onset seizures are more common in atrial fibrillation, possibly linked by silent strokes, an observational study suggested.

Read more


ESC: Warfarin May Lower Dementia Risk in Afib Patients

MedPage Today, 3 September 2015

Patients with incident atrial fibrillation who were treated with warfarin to reduce the risk of strokes may also have had less chance of developing dementia, researchers suggested here.

Read more


Clinical trials launching to test iRhythm Zio Patch for atrial fibrillation screening in nearly 3,000 patients

MedPage Today, 3 September 2015

Two major studies are set to launch in the United States and Canada evaluating the use of the Zio Patch, a wearable ECG monitor, to screen for silent atrial fibrillation.

Read more


ESC recommends subcutaneous defibrillators for management of ventricular arrhythmias and prevention of sudden cardiac death

Cardiac Rhythm News, 2 September 2015

Updated ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have been announced during the ESC Congress 2015 (29 August–2 September, London, UK).

Read more


Ready for Rio, but